| Dr Mark J Hornyak, MD | |
|
1 Atwell Rd, Cooperstown, NY 13326-1301 | |
| (607) 547-3334 | |
| (607) 547-4067 |
| Full Name | Dr Mark J Hornyak |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 24 Years |
| Location | 1 Atwell Rd, Cooperstown, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124226394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 62295 (Connecticut) | Primary |
| 207T00000X | Neurological Surgery | 4301090199 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| William W Backus Hospital | Norwich, CT | Hospital |
| Windham Community Memorial Hospital | Willimantic, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.
GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.
The direct oral factor Xa inhibitor darexaban is effective for the prevention of venous thromboembolism in Japanese patients undergoing major abdominal surgery, researchers find.
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
A new study reveals that women living in coastal areas and in the Northeast U.S. were more likely than other women to have blood mercury (BHg) concentrations exceeding levels of concern, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 6 days ago
| Entity Name | Hartford Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043561301 PECOS PAC ID: 1153573902 Enrollment ID: O20121201000007 |
News Archive
In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.
GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.
The direct oral factor Xa inhibitor darexaban is effective for the prevention of venous thromboembolism in Japanese patients undergoing major abdominal surgery, researchers find.
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
A new study reveals that women living in coastal areas and in the Northeast U.S. were more likely than other women to have blood mercury (BHg) concentrations exceeding levels of concern, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 6 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.
GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.
The direct oral factor Xa inhibitor darexaban is effective for the prevention of venous thromboembolism in Japanese patients undergoing major abdominal surgery, researchers find.
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
A new study reveals that women living in coastal areas and in the Northeast U.S. were more likely than other women to have blood mercury (BHg) concentrations exceeding levels of concern, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark J Hornyak, MD 1 Towne Park Plz, Norwich, CT 06360-2247 Ph: (607) 547-3334 | Dr Mark J Hornyak, MD 1 Atwell Rd, Cooperstown, NY 13326-1301 Ph: (607) 547-3334 |
News Archive
In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters.
GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.
The direct oral factor Xa inhibitor darexaban is effective for the prevention of venous thromboembolism in Japanese patients undergoing major abdominal surgery, researchers find.
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
A new study reveals that women living in coastal areas and in the Northeast U.S. were more likely than other women to have blood mercury (BHg) concentrations exceeding levels of concern, as reported in the January 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP).
› Verified 6 days ago
Dr. Frank Allen Zimba, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 286 County Highway 33, Cooperstown, NY 13326 Phone: 716-640-1670 | |
Peter Leroux, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3480 | |
Dr. Craig R Goldberg, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Atwell Rd, Cooperstown, NY 13326 Phone: 607-547-3334 Fax: 607-547-4786 |